You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hlx208

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial (HLX208, Itraconazole 200 mg, Rifampicin)

Not yet recruiting
  • NSCLC
  • HLX208
  • +2 more
  • (no location specified)
Jun 5, 2023

Metastatic Colorectal Cancer, mCRC Trial in Shenyang (HLX208)

Recruiting
  • Metastatic Colorectal Cancer
  • mCRC
  • HLX208
  • Shenyang, Liaoning, China
    Liaoning Cancer Hospital
May 1, 2022

Brain Tumor, Primary Trial in Jinan (HLX208)

Recruiting
  • Brain Tumor, Primary
  • HLX208
  • Jinan, Shandong, China
    Cancer Hospital Affiliated to Shandong first medical University
May 1, 2022

Advanced Melanoma Trial in China (HLX208)

Recruiting
  • Advanced Melanoma
  • HLX208
  • Peking, Beijing, China
  • +6 more
May 1, 2022

NSCLC Trial in Shanghai (HLX208)

Recruiting
  • NSCLC
  • HLX208
  • Shanghai, China
    Shanghai chest hospital
Jan 5, 2022

Anaplastic Thyroid Cancer, ATC Trial in Shanghai (HLX208)

Recruiting
  • Anaplastic Thyroid Cancer
  • ATC
  • HLX208
  • Shanghai, China
    Fudan University Affiliated Oncology Hospital
Dec 30, 2021

CRC Trial in Shanghai (HLX208, Cetuximab Injection [Erbitux])

Recruiting
  • CRC
  • HLX208
  • Cetuximab Injection [Erbitux]
  • Shanghai, China
    Fudan University Affiliated Oncology Hospital
Dec 30, 2021

Langerhans Cell Histiocytosis, Erdheim-Chester Disease, LCH Trial in Beijing (HLX208)

Recruiting
  • Langerhans Cell Histiocytosis
  • +3 more
  • HLX208
  • Beijing, China
    Peking Union Medical College Hospital
Dec 30, 2021